Thyroid Cancer Clinical Trials Intelligence
Monthly Update Report for Trials Started in December 2025
Powered by Sophic Starlight
Sophic does not practice medicine nor provide medical advice. The Sophic Starlight Cancer Clinical Trials Intelligence Report is provided for educational and consulting purposes only. This report is not a substitute for professional medical advice, diagnosis, or treatment. Sophic shall not be held responsible for any interpretation, application, or use of this report beyond these purposes.
The Sophic Starlight Cancer Clinical Trials Intelligence Report is intended solely as an educational resource that provides access to publicly available clinical trial data integrated within Sophic’s proprietary knowledgebase and summarized with AI. Reports are provided entirely free of charge, and patients should never be billed or charged for access to this information. Users agree to reference Sophic in any publication, presentation, or publicity that incorporates or relies upon information from Sophic Starlight Cancer Clinical Trials Intelligence Reports.
1: Summary data from new trials identified for Thyroid Cancer.
Overview
Number of Trials: 1
This trial evaluates lavender aromatherapy versus placebo for reducing anxiety and pain in adults undergoing awake outpatient otolaryngologic procedures. It targets patients not on recent pain or psychotropic medications.
Common Criteria Across Trials
Common Inclusion
- Adults 18 years or older
- Undergoing awake otolaryngologic procedures in outpatient clinic
- Able to provide informed consent
Common Exclusion
- Hypersensitivity to fragrances
- Systemic NSAIDs or pain medications within 48 hours
- Regular use of anxiolytics, hypnotics, sedating antihistamines, or antidepressants within 4 weeks
- Pregnant or breastfeeding
- Participation in another clinical trial within 30 days
2: Extracted Trials with New Information
Trials with Special Criteria
Unique or Unusual Criteria
- NCT07299474 — Excludes patients with hypersensitivity to fragrances, which is specific to aromatherapy interventions.
Trials with Emerging Treatments
- NCT07299474 — Efficacy Of Lavender Aromatherapy on Anxiety and Pain Reduction During Awake Otolaryngologic Procedures
Items: Lavender Aromatherapy
Note: Non-pharmacologic intervention using lavender essential oil for procedural anxiety and pain management in outpatient ENT setting.
3: Individual Trial Overviews
NCT07299474
Efficacy Of Lavender Aromatherapy on Anxiety and Pain Reduction During Awake Otolaryngologic Procedures
Organization/Sponsor: Cedars-Sinai Medical Center
Example patient: A 45-year-old non-pregnant adult undergoing an awake thyroid biopsy in the outpatient clinic who has not taken pain medications or antidepressants recently and has no fragrance allergies.
Phase N/A
NCT07299474
Efficacy Of Lavender Aromatherapy on Anxiety and Pain Reduction During Awake Otolaryngologic Procedures
Organization/Sponsor: Cedars-Sinai Medical Center
Example patient: A 45-year-old non-pregnant adult undergoing an awake thyroid biopsy in the outpatient clinic who has not taken pain medications or antidepressants recently and has no fragrance allergies.
Interventions
-
Aromatherapy: Placebo Aromatherapy
Summary: An inactive substance providing baseline measurements for experimental protocol comparison (NCI Thesaurus). -
Aromatherapy: Lavender Aromatherapy
Summary: Essential oil from Lavandula flowers used for aromatic properties in aromatherapy to reduce anxiety and pain (NCI Thesaurus).
Key Inclusion
- Adults ≥18 years old
- Undergoing awake otolaryngologic procedures
- Outpatient clinic setting
- Able to provide informed consent
Key Exclusion
- Hypersensitivity to fragrances
- Systemic NSAIDs or pain medications within 48 hours
- Anxiolytics, hypnotics, sedating antihistamines, or antidepressants within 4 weeks
- Pregnant or breastfeeding
- Participation in another clinical study within 30 days